Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework

Abstract The objectives of the study were to use tumor size data from 10 phase II/III atezolizumab studies across five solid tumor types to estimate tumor growth inhibition (TGI) metrics and assess the impact of TGI metrics and baseline prognostic factors on overall survival (OS) for each tumor type...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Phyllis Chan, Mathilde Marchand, Kenta Yoshida, Shweta Vadhavkar, Nina Wang, Alyse Lin, Benjamin Wu, Marcus Ballinger, Nitzan Sternheim, Jin Y. Jin, René Bruno
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2021-10-01
Edice:	CPT: Pharmacometrics & Systems Pharmacology
On-line přístup:	https://doi.org/10.1002/psp4.12686
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!